Avadel Pharmaceuticals (AVDL)
6.82
-0.38 (-5.28%)
At close: Apr 04, 2025, 3:59 PM
6.53
-4.25%
After-hours: Apr 04, 2025, 05:43 PM EDT
Avadel Pharmaceuticals Revenue
Avadel Pharmaceuticals reported an annual revenue of $169.12M, reflecting a 504.79% growth. For the quarter ending December 31, 2024, Avadel Pharmaceuticals generated $50.41M in revenue.
Revenue (ttm)
$169.12M
Revenue Growth
504.79%
Price / Sales Ratio
5.91
Revenue / Employee
$899.56K
Employees
188
Market Cap
659.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 169.12M | +504.79% |
| Dec 31, 2023 | 27.96M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | -100.00% |
| Dec 31, 2020 | 22.33M | n/a |